Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsz Y Yeung

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancers|August 29, 2024
MERTK Is a Potential Therapeutic Target in Ewing SarcomaSherri K Smart, Tsz Y Yeung, M Olivia Santos, et al.
Cancers|December 23, 2022
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic LeukemiaRyan J Summers, Juhi Jain, Eleana Vasileiadi, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitorsMegan D Hopkins, Dehui Zhang, Zhilong Chen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancers|August 29, 2024
MERTK Is a Potential Therapeutic Target in Ewing SarcomaSherri K Smart, Tsz Y Yeung, M Olivia Santos, et al.
Cancers|December 23, 2022
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic LeukemiaRyan J Summers, Juhi Jain, Eleana Vasileiadi, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitorsMegan D Hopkins, Dehui Zhang, Zhilong Chen, et al.
Pageof 1